Related Experiment Video
Updated: May 16, 2026

06:19
Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
[Preservatives from the perspective of glaucoma surgery]
1Universitätsaugenklinik, Otto von Guericke Universität, Leipziger Str. 44, 39120, Magdeburg, Deutschland. hagen.thieme@med.ovgu.de
Summary
Trabeculectomy is the gold standard for glaucoma surgery, aiming for optimal bleb formation. Abolishing preservatives like benzalkonium chloride in glaucoma eye drops is crucial for enhancing surgical success rates.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Glaucoma Research
Context:
- Trabeculectomy remains the primary surgical intervention for glaucoma management.
- Successful bleb development is critical for achieving target intraocular pressure (IOP).
- Bleb failure due to scar tissue formation is a significant clinical challenge.
Purpose:
- To investigate factors influencing trabeculectomy success rates.
- To highlight the impact of topical antiglaucoma medications on surgical outcomes.
- To emphasize the role of preservatives in bleb healing and function.
Summary:
- Trabeculectomy success hinges on conjunctival status and bleb function for IOP control.
- Antiproliferative agents (mitomycin C, 5-fluorouracil) are used but scar tissue formation remains common.
- Chronic topical antiglaucoma drug use, particularly preservatives like benzalkonium chloride, impairs wound healing and bleb formation.
Impact:
- Complete cessation of topical antiglaucoma drugs 4-6 weeks pre-surgery is recommended.
- Eliminating benzalkonium chloride is essential for improving trabeculectomy outcomes.
- This research informs clinical practice to optimize glaucoma surgical success.
Related Concept Videos
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...